Characterization of a Novel Mouse Model for Fuchs Endothelial Corneal Dystrophy
Investigative Opthalmology & Visual Science · 2024-04-08 · 65 (4) · 18
DOI: 10.1167/iovs.65.4.18 ↗At a glance
Journal article in Investigative Opthalmology & Visual Science, published on 2024-04-08. Written by Subashree Murugan and 4 co-authors. Institution: Vision Science Program, School of Optometry, Indiana University Bloomington, Indiana, United States. Major MEDLINE topics: Fuchs' Endothelial Dystrophy, Symporters. Cited 11 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Purpose
Fuchs endothelial corneal dystrophy (FECD) is a progressive blinding disorder, characterized by increased corneal endothelial excrescences (guttae), corneal endothelial cell loss, and edema. These symptoms are hypothesized to be caused by changes in the extracellular matrix (ECM) and mitochondrial dysfunction in the corneal endothelium. Despite this clinical and biological relevance, a comprehensive animal model that recapitulates all the major disease characteristics is currently unavailable. In this study, we develop such a model to improve our understanding of the signaling pathways involved in the FECD progression and develop strategies for early intervention.
Method
To generate a comprehensive FECD model, we generated a double mutant mouse bearing tamoxifen-inducible knockdown of Slc4a11 and the Col8a2 (Q455K) mutation. We performed optical coherence tomography (OCT) and in vivo confocal microscopy using the Heidelberg Retinal Tomography 3 - Rostock Cornea module (HRT3-RCM) on the mice at 5 weeks of age before tamoxifen feeding to establish baseline values for corneal thickness, endothelial cell density, and test for the presence of guttae. We measured these parameters again post-tamoxifen treatment at 16 weeks of age. We collected corneas at 16 weeks to perform histopathology, immunofluorescence staining for tight junctions, adherens junctions, and oxidative stress. We evaluated endothelial pump function using a lactate assay.
Results
The double mutant tamoxifen-fed animals showed the presence of guttae, and displayed increased corneal thickness and decreased endothelial cell density. Endothelial cells showed altered morphology with disrupted adherens junctions and elevated reactive oxygen species (ROS). Finally, we found that stromal lactate concentrations were elevated in the double mutant mice, indicative of compromised endothelial pump function.
Conclusions
Overall, this mouse model recapitulates all the important phenotypic features associated with FECD.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Vision Science Program, School of Optometry, Indiana University Bloomington, Indiana, United States.
- Department of Biology, Indiana University Bloomington, Indiana, United States.
Funding
- NEI NIH HHS
Cite
APA
Murugan, S., de Campos, V. S., Ghag, S. A., Ng, M., & Shyam, R. (2024). Characterization of a Novel Mouse Model for Fuchs Endothelial Corneal Dystrophy. Investigative Opthalmology & Visual Science, 65(4), 18. https://doi.org/10.1167/iovs.65.4.18
Vancouver
Murugan S, de Campos VS, Ghag SA, Ng M, Shyam R. Characterization of a Novel Mouse Model for Fuchs Endothelial Corneal Dystrophy. Investigative Opthalmology & Visual Science. 2024;65(4):18. doi:10.1167/iovs.65.4.18
BibTeX
@article{Murugan2024,
author = {Murugan, Subashree and de Campos, Viviane Souza and Ghag, Sachin Anil and Ng, Matthew and Shyam, Rajalekshmy},
title = {Characterization of a Novel Mouse Model for Fuchs Endothelial Corneal Dystrophy},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
volume = {65},
number = {4},
pages = {18},
doi = {10.1167/iovs.65.4.18}
}
EUVIMED